Effectiveness of an Internet-based Intervention for the Treatment of Depression (ASCENSO)
Primary Purpose
Depression
Status
Completed
Phase
Not Applicable
Locations
Chile
Study Type
Interventional
Intervention
ASCENSO
Antidepressants or in combination with anxiolytics, neuroleptics or mood stabilizers.
Psychotherapy
Sponsored by

About this trial
This is an interventional treatment trial for Depression focused on measuring Internet, Mental Health
Eligibility Criteria
Inclusion Criteria:
- Clinical diagnosis of major depression disorder
- Internet access
Exclusion Criteria:
- previous suicide attempt
- hospitalization for a previous depressive episode
- a history of psychotic symptoms
- bipolar disorder
- organic brain disorders
- any serious disorders related to substance abuse or dependence
- antisocial personality disorder
- a serious medical condition or severe cognitive impairment
- lack of knowledge of the Spanish language
- illiteracy
- refusal or revocation of patient consent.
Patients will be evaluated using the MINI International Neuropsychiatric interview, Spanish for Chile Translation Version 6.0.0.
Sites / Locations
- Psicomedica
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Experimental
Control
Arm Description
Participants receive psychiatric treatment and psychotherapy as usual. In addition, participants have access to the internet-based program ASCENSO: an adjunct support and monitoring system for the treatment of depression.
Patients receive psychiatric treatment and psychotherapy as usual.
Outcomes
Primary Outcome Measures
Change in depressivity assessed with the Beck's Depression Inventory I (BDI-I)
Beck's Depression Inventory I (BDI-I) total score (score range 0 - 63)
Secondary Outcome Measures
Change in quality of life change assessed with the EuroQol/EQ-5D
EuroQol/EQ-5D (EQ-index range 0 - 1)
Full Information
NCT ID
NCT03093467
First Posted
March 14, 2017
Last Updated
April 5, 2021
Sponsor
Instituto Milenio para Investigación en Depresión y Personalidad
Collaborators
Psicomedica Clinical & Research Group, Chile, University Hospital Heidelberg, National Fund for Research and Development in Health, Chile
1. Study Identification
Unique Protocol Identification Number
NCT03093467
Brief Title
Effectiveness of an Internet-based Intervention for the Treatment of Depression
Acronym
ASCENSO
Official Title
Effectiveness of an Internet-based Intervention for the Treatment of Depression: Towards the Improvement of the Management of Depression
Study Type
Interventional
2. Study Status
Record Verification Date
April 2021
Overall Recruitment Status
Completed
Study Start Date
May 29, 2017 (Actual)
Primary Completion Date
November 13, 2019 (Actual)
Study Completion Date
November 13, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Instituto Milenio para Investigación en Depresión y Personalidad
Collaborators
Psicomedica Clinical & Research Group, Chile, University Hospital Heidelberg, National Fund for Research and Development in Health, Chile
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Depression is a highly prevalent disorder in Chile, generating important personal and social costs. This study aims to evaluate the effectiveness of the internet-based program ASCENSO as an adjunct intervention for the treatment of depression. ASCENSO provides information to promote patients' self-care, it monitors reported depression symptoms providing automatized feedback and provides the possibility of booking a counseling session via chat or by phone. To evaluate the effectiveness of ASCENSO, an open, evaluator-blind, prospective, parallel-group (one intervention group and one active control group) randomized controlled trial will be implemented in one mental health center in Santiago of Chile. The sample will be composed of adults initiating treatment for depression, and who have internet access. Participants will be randomly assigned to one of the two study arms. Randomization will be stratified by the number of patients´ previous episodes (dichotomized into none, 1 or more), following a permuted block randomization procedure. Patients in the experimental group (n=100) will receive the usual treatment plus access to the ASCENSO program. The control group (n=100) will only receive the usual treatment. At recruitment, months 6 and 9, patients' self-reported depression symptoms and quality of life will be assessed. Additionally, adherence to treatment in terms of patients' attendance to medical controls and psychotherapy sessions will be registered for both research groups.
Detailed Description
The public health system has established policies and priorities to provide access to depression treatment and to improve the quality of those services. The acknowledgment of the complexity and chronicity of the disorder has motivated the design and implementation of comprehensive disease management strategies for depression. There are experiences that show that information technologies can help to optimize the management of depression. If ASCENSO is effective, it could be a useful resource to include to the mental health services for depression in Chile.
The components of the ASCENSO program are:
Emergency. Standard Information on what to do and who to contact in a crisis situation.
Online or phone counseling. Patients can schedule a 30-minute session with a psychologist, which is conducted in a private text chatroom or over the phone.
Monitoring. Patients receive a bi-weekly email with a link to the monitoring questionnaire and automatized tailored feedback message. If a participant reports severe impairment, the ASCENSO administrator receives an alert notification and then contacts the patient.
Self-care information and blog. Web pages with basic information about depression and self-care recommendations.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depression
Keywords
Internet, Mental Health
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Open randomized controlled trial in one mental health center.
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
167 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Experimental
Arm Type
Experimental
Arm Description
Participants receive psychiatric treatment and psychotherapy as usual. In addition, participants have access to the internet-based program ASCENSO: an adjunct support and monitoring system for the treatment of depression.
Arm Title
Control
Arm Type
Active Comparator
Arm Description
Patients receive psychiatric treatment and psychotherapy as usual.
Intervention Type
Behavioral
Intervention Name(s)
ASCENSO
Other Intervention Name(s)
Internet-based program
Intervention Description
Internet-based program: an adjunct support and monitoring system for the treatment of depression.
Intervention Type
Drug
Intervention Name(s)
Antidepressants or in combination with anxiolytics, neuroleptics or mood stabilizers.
Other Intervention Name(s)
Psychiatric treatment
Intervention Description
Usual psychiatric treatment which may include drugs: antidepressant monotherapy or antidepressants in combination with anxiolytics, neuroleptics or mood stabilizers as needed, according to the psychiatric evaluation. Monthly controls during 5 months in average.
Intervention Type
Behavioral
Intervention Name(s)
Psychotherapy
Intervention Description
Usual treatment: brief psychotherapy. One session per week, a total of 9 sessions in average.
Primary Outcome Measure Information:
Title
Change in depressivity assessed with the Beck's Depression Inventory I (BDI-I)
Description
Beck's Depression Inventory I (BDI-I) total score (score range 0 - 63)
Time Frame
Baseline, months 6 and 9.
Secondary Outcome Measure Information:
Title
Change in quality of life change assessed with the EuroQol/EQ-5D
Description
EuroQol/EQ-5D (EQ-index range 0 - 1)
Time Frame
Baseline, months 6 and 9.
Other Pre-specified Outcome Measures:
Title
Number of attended and missed treatment appointments
Description
Adherence to treatment in terms of patients' attendance to medical controls and psychotherapy sessions.
Time Frame
Months 6 and 9.
Title
Number of patients that dropout from treatment
Description
Number of patients that dropout from psychiatric or psychotherapeutic treatment during the observation period.
Time Frame
Months 6 and 9.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Clinical diagnosis of major depression disorder
Internet access
Exclusion Criteria:
previous suicide attempt
hospitalization for a previous depressive episode
a history of psychotic symptoms
bipolar disorder
organic brain disorders
any serious disorders related to substance abuse or dependence
antisocial personality disorder
a serious medical condition or severe cognitive impairment
lack of knowledge of the Spanish language
illiteracy
refusal or revocation of patient consent.
Patients will be evaluated using the MINI International Neuropsychiatric interview, Spanish for Chile Translation Version 6.0.0.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Álvaro E. Carrasco, PhD
Organizational Affiliation
Millennium institute for research on depression and personality (MIDAP)
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Janet C. Pérez, PhD
Organizational Affiliation
Millennium institute for research on depression and personality (MIDAP)
Official's Role
Principal Investigator
Facility Information:
Facility Name
Psicomedica
City
Santiago
State/Province
RM
Country
Chile
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Individual quantitative participant data that underlie the reported results, after deidentification (text, tables and figures).
IPD Sharing Time Frame
Beginning 3 months and ending 5 years following article publication
IPD Sharing Access Criteria
These data will be available to researchers who provide a methodologically sound proposal for the purposes of achieving specific aims outlined in that proposal. Proposals should be directed to J. Carola Pérez via email (janetperez@udd.cl) or Olga Fernandez (mofernandez36@gmail.com) and will be reviewed by both researchers. Requests to access data to undertake hypothesis-driven research will not be unreasonably withheld. To gain access, data requesters will need to sign a data access agreement and to confirm that data will only be used for the agreed purpose for which access was granted and this these data will be not shared to other people.
Citations:
PubMed Identifier
22051709
Citation
Alvarado R, Rojas G. [Evaluation of the program for detection and treatment of depression in Chilean primary health care centers]. Rev Med Chil. 2011 May;139(5):592-9. Epub 2011 Sep 16. Spanish.
Results Reference
background
PubMed Identifier
20183695
Citation
Andersson G, Cuijpers P. Internet-based and other computerized psychological treatments for adult depression: a meta-analysis. Cogn Behav Ther. 2009;38(4):196-205. doi: 10.1080/16506070903318960.
Results Reference
background
PubMed Identifier
26741190
Citation
Espinosa HD, Carrasco A, Moessner M, Caceres C, Gloger S, Rojas G, Perez JC, Vanegas J, Bauer S, Krause M. Acceptability Study of "Ascenso": An Online Program for Monitoring and Supporting Patients with Depression in Chile. Telemed J E Health. 2016 Jul;22(7):577-83. doi: 10.1089/tmj.2015.0124. Epub 2016 Jan 7.
Results Reference
background
PubMed Identifier
17657327
Citation
Fritsch R, Araya R, Solis J, Montt E, Pilowsky D, Rojas G. [A randomized trial of pharmacotherapy with telephone monitoring to improve treatment of depression in primary care in Santiago, Chile]. Rev Med Chil. 2007 May;135(5):587-95. Epub 2007 Jul 9. Spanish.
Results Reference
background
PubMed Identifier
25803266
Citation
Hamine S, Gerth-Guyette E, Faulx D, Green BB, Ginsburg AS. Impact of mHealth chronic disease management on treatment adherence and patient outcomes: a systematic review. J Med Internet Res. 2015 Feb 24;17(2):e52. doi: 10.2196/jmir.3951.
Results Reference
background
PubMed Identifier
26808817
Citation
Kordy H, Wolf M, Aulich K, Burgy M, Hegerl U, Husing J, Puschner B, Rummel-Kluge C, Vedder H, Backenstrass M. Internet-Delivered Disease Management for Recurrent Depression: A Multicenter Randomized Controlled Trial. Psychother Psychosom. 2016;85(2):91-8. doi: 10.1159/000441951. Epub 2016 Jan 26.
Results Reference
background
PubMed Identifier
15550801
Citation
Neumeyer-Gromen A, Lampert T, Stark K, Kallischnigg G. Disease management programs for depression: a systematic review and meta-analysis of randomized controlled trials. Med Care. 2004 Dec;42(12):1211-21. doi: 10.1097/00005650-200412000-00008.
Results Reference
background
PubMed Identifier
34927594
Citation
Perez JC, Fernandez O, Caceres C, Carrasco AE, Moessner M, Bauer S, Espinosa-Duque D, Gloger S, Krause M. An Adjunctive Internet-Based Intervention to Enhance Treatment for Depression in Adults: Randomized Controlled Trial. JMIR Ment Health. 2021 Dec 16;8(12):e26814. doi: 10.2196/26814.
Results Reference
derived
Links:
URL
http://ww3.psicomedica.cl/
Description
Mental health clinic. Recruitment center.
URL
http://midap.org
Description
Millennium Institute for research on depression and personality
URL
http://psyres.de/
Description
Center for psychotherapy research, Heidelberg University Hospital
URL
http://www.conicyt.cl/fonis/
Description
Fund for research and development in health
Learn more about this trial
Effectiveness of an Internet-based Intervention for the Treatment of Depression
We'll reach out to this number within 24 hrs